Skip to main content
Board of Directors
Innovation engine overview
Extracting microbial biodiversity
Screening for new activity
Active compound characterization
Technology platform overview
DEINOVE is pioneering the exploration of “microbial dark matter”
By revealing the metabolic potential of rare bacteria or still classified as uncultivable, the company tackles a global health and economic challenge:
DEINOVE- Second convening to a Combined General Meeting on June 21, 2021
DEINOVE (Euronext Growth Paris: ALDEI), a French biotech company, pioneer in the exploration and...
DEINOVE, ESPCI Paris and INRAE awarded grant following the call for proposals of the French “Antibiotic resistance” Priority Research Program
The Microflu4AMR project, based on microfluidic technology and the exploitation of soil microbial...
More press releases